NCT04862663 2026-04-20
CAPItello-292
AstraZeneca
Phase 3 Recruiting
Clinical Trials
6 trialsNCT07241065 2026-04-15
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
AstraZeneca
Phase 1 Recruiting
NCT07343960 2026-04-09
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
Phase 1 Recruiting
NCT06982521 2026-04-02
ReDiscover-2
Relay Therapeutics, Inc.
Phase 3 Recruiting
NCT07287917 2026-03-12
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Aminex Therapeutics, Inc.
Phase 1/2 Recruiting
NCT05563220 2026-01-06
ELEVATE
Stemline Therapeutics, Inc.
Phase 1/2 Recruiting